CS logo
small CS logo
Delbert Day Cancer Institute at PCRMC

Rolla, Missouri, United States
Medical clinic in Rolla, Missouri
1060 W 10th St, Rolla, MO 65401

About Delbert Day Cancer Institute at PCRMC


"The nationally accredited Delbert Day Cancer Institute (DDCI) at Phelps Health provides all cancer care services under one roof for convenience and continuity of care for patients and their families."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
117
SWOG Cancer Research Network
36
Alliance for Clinical Trials in Oncology
32
ECOG-ACRIN Cancer Research Group
19
NRG Oncology
16
Gynecologic Oncology Group
7
Wake Forest University Health Sciences
6
GOG Foundation
4
Radiation Therapy Oncology Group
2
Eastern Cooperative Oncology Group
1
National Heart, Lung, and Blood Institute (NHLBI)
1
Total Rows: 11

Clinical Trials at Delbert Day Cancer Institute at PCRMC


During the past decade, Delbert Day Cancer Institute at PCRMC conducted 158 clinical trials. In the 10-year time frame, 158 clinical trials started and 83 clinical trials were completed, i.e. on average, 52.5% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 54 clinical trials were completed. i.e. 108% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years151516161818252534343232171711222222991414161619191515Started TrialsCompleted Trails2015201620172018201920202021202202040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052

Rows per page:

1–100 of 241

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Delbert Day Cancer Institute at PCRMC" #1 sponsor was "National Cancer Institute (NCI)" with 117 trials, followed by "SWOG Cancer Research Network" with 36 trials sponsored, "Alliance for Clinical Trials in Oncology" with 32 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 19 trials sponsored and "NRG Oncology" with 19 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Delbert Day Cancer Institute at PCRMC" #1 collaborator was "National Cancer Institute (NCI)" with 123 trials as a collaborator, "NRG Oncology" with 30 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 24 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 117National CancerInstitute (NCI): 117SWOG Cancer ResearchNetwork: 36SWOG Cancer ResearchNetwork: 36Alliance for ClinicalTrials in Oncology: 32Alliance for ClinicalTrials in Oncology: 32ECOG-ACRIN CancerResearch Group: 19ECOG-ACRIN CancerResearch Group: 19NRG Oncology: 16NRG Oncology: 16Gynecologic Oncology Group: 7Gynecologic Oncology Group: 7Wake Forest UniversityHealth Sciences: 6Wake Forest UniversityHealth Sciences: 6GOG Foundation: 4GOG Foundation: 4Radiation TherapyOncology Group: 2Radiation TherapyOncology Group: 2Eastern CooperativeOncology Group: 1Eastern CooperativeOncology Group: 1

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 123National CancerInstitute (NCI): 123NRG Oncology: 30NRG Oncology: 30Canadian Cancer Trials Group: 8Canadian Cancer Trials Group: 8Genentech, Inc.: 3Genentech, Inc.: 3MillenniumPharmaceuticals, Inc.: 3MillenniumPharmaceuticals, Inc.: 3Daiichi Sankyo, Inc.: 2Daiichi Sankyo, Inc.: 2SWOG Cancer ResearchNetwork: 2SWOG Cancer ResearchNetwork: 2Bayer: 1Bayer: 1Biologics, Inc.: 1Biologics, Inc.: 1Brain Science Foundation: 1Brain Science Foundation: 1

Clinical Trials Conditions at Delbert Day Cancer Institute at PCRMC


According to Clinical.Site data, the most researched conditions in "Delbert Day Cancer Institute at PCRMC" are "Invasive Breast Carcinoma" (11 trials), "Recurrent Breast Carcinoma" (9 trials), "Recurrent Ovarian Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Stage IV Lung Cancer AJCC v8" (9 trials). Many other conditions were trialed in "Delbert Day Cancer Institute at PCRMC" in a lesser frequency.

Clinical Trials Intervention Types at Delbert Day Cancer Institute at PCRMC


Most popular intervention types in "Delbert Day Cancer Institute at PCRMC" are "Drug" (189 trials), "Other" (153 trials), "Biological" (99 trials), "Procedure" (68 trials) and "Radiation" (47 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (77 trials), "Quality-of-Life Assessment" (60 trials), "Questionnaire Administration" (40 trials), "Biospecimen Collection" (35 trials) and "Cisplatin" (33 trials). Other intervention names were less common.

Clinical Trials Genders at Delbert Day Cancer Institute at PCRMC


The vast majority of trials in "Delbert Day Cancer Institute at PCRMC" are 189 trials for "All" genders, 41 trials for "Female" genders and 11 trials for "Male" genders.

Clinical Trials Status at Delbert Day Cancer Institute at PCRMC


Currently, there are NaN active trials in "Delbert Day Cancer Institute at PCRMC". undefined are not yet recruiting, 80 are recruiting, 108 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Delbert Day Cancer Institute at PCRMC, 9 suspended trials, and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Delbert Day Cancer Institute at PCRMC, 7 "Phase 1" clinical trials were conducted, 126 "Phase 2" clinical trials and 115 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 126Phase 2: 126Phase 3: 115Phase 3: 115Phase 1: 7Phase 1: 7Not Applicable: 6Not Applicable: 6Early Phase 1: 2Early Phase 1: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 108Active, not recruiting: 108Recruiting: 80Recruiting: 80Completed: 33Completed: 33Suspended: 9Suspended: 9Terminated: 9Terminated: 9Unknown status: 2Unknown status: 2